CYTBIOSCIENCE, INC.

Profile

Company Names

CYTBIOSCIENCE, INC.
CYTOBIOSCIENCE, INC.
CYTOCENTRICS, INC.

Addresses

3463 MAGIC DRIVE, SUITE 120, SAN ANTONIO, TX 78229

18618 TUSCANY STONE, SUITE 120, SAN ANTONIO, TX 78258

Phone Numbers

210-767-2727
941-914-1200

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

2014

State Incorporated:

DELAWARE

Total Amount Raised:

$18,881,845.00

Number of Funding Rounds:

4
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
4
2018-03-14 
$1,530,000.00 
$1,530,000.00 
$0.00 
Equity 
3
2018-03-01 
$1,530,000.00 
$1,530,000.00 
$0.00 
Equity 
2
2015-03-11 
$15,821,845.00 
$21,821,845.00 
$6,000,000.00 
Equity 
1
2015-03-06 
$0.00 
INDEFINITE 
INDEFINITE 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
PAUL 
 
CASTELLA 
DIRECTOR
BIO2 MEDICAL INC   |  VIROXIS CORP   |  BI02 MEDICAL, INC.   |  CYTOCENTRICS, INC.   |  STEMBIOSYS INC.   |  CYTBIOSCIENCE, INC.   |  CYTOBIOSCIENCE, INC.   |  HERA BIOTECH, INC.   |  INNOVATIVE TRAUMA CARE INC.   |  TROPOFLEX INC.   |  TROPOGENIX, INC.
IAN 
 
CLEMENTS 
DIRECTOR
TARGETED TECHNOLOGY FUND II, LP   |  CYTOCENTRICS, INC.   |  STEMBIOSYS INC.   |  CYTBIOSCIENCE, INC.   |  CYTOBIOSCIENCE, INC.   |  MIRUM PHARMACEUTICALS, INC.
ALAN 
 
DEAN 
DIRECTOR
VIROXIS CORP   |  BI02 MEDICAL, INC.   |  BIODTECH INC   |  BLUEGRASS VASCULAR TECHNOLOGIES, INC.   |  CYTOCENTRICS, INC.   |  CYTBIOSCIENCE, INC.   |  CYTOBIOSCIENCE, INC.
JAMES 
R. 
GARVIN 
EXECUTIVE OFFICER, DIRECTOR
CYTOCENTRICS, INC.   |  CYTBIOSCIENCE, INC.   |  CYTOBIOSCIENCE, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2018-03-16
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2018-03-01 
2018-03-15
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2018-03-14 
2018-01-23
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2015-03-11 
2018-01-22
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2015-03-11 
2016-08-10
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2015-03-11 
2015-03-26
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2015-03-11 
2015-03-26
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2015-03-06 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
DIVINE CAPITAL MARKETS
118212
DANIELLE HUGHES
2189447
DIVINE CAPITAL MARKETS LLC
118212
JIM GARVIN
6219942